The ASX has stated that it will afford the Company until 1 November 2017 to demonstrate to ASX that it is compliant with listing rule 12.1. Today's the dead-line, mate.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025